[Adrenergic beta receptor blockaders in the treatment of mental disorders].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000526:Alprenolol / Q000627:therapeutic use; D004341:Drug Evaluation; D006801:Humans; D010096:Oxprenolol / Q000627:therapeutic use; D010869:Pindolol / Q000627:therapeutic use; D011217:Practolol / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use; D011618:Psychotic Disorders / Q000188:drug therapy*; D013015:Sotalol / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D010096:Oxprenolol; D000526:Alprenolol; D011433:Propranolol; D013015:Sotalol; D010869:Pindolol; D011217:Practolol
Leki blokujace receptor adrenergiczny w terapii zaburzeń psychicznych.